Complement activation in non-small cell lung cáncer and its effect on tumor progresión
Director: 
Palabras clave : 
Cáncer
Tumores
Células
Materias Investigacion::Ciencias de la Salud::Oncología
Fecha de publicación: 
2012
Fecha de la defensa: 
18-mar-2011
Editorial : 
Servicio de Publicaciones de la Universidad de Navarra
ISBN: 
84-8081-130-7
Cita: 
CORRALES PECINO, Leticia. “Complement activation in non-small cell lung cáncer and its effect on tumor progresión”. Pío Oses, Rubén. Tesis doctoral. Universidad de Navarra, 2011
Resumen
HYPOTHESIS The hypothesis of the present work is that tumor cells express on their surface tumorassociated antigens that have the potential to activate the complement system. At the same time, tumor cells have developed mechanisms that make them resistant to complement cytotoxic effects. The subsequent effects of complement activation on complement-resistant cancer cells play a pivotal role in the development of malignant features, ending in tumor progression. OBJECTIVES 1. To study complement activation by the alternative and classical pathways on non-small cell lung cancer (NSCLC) cells and normal bronchial epithelial cells. 2. To study the expression, at the mRNA and protein levels, of the main complement inhibitory proteins in NSCLC and normal bronchial epithelial cells. 3. To study the role of complement in a syngeneic mouse model of lung cancer, with special interest in tumor-associated characteristics of the microenvironment such as angiogenesis and immunosuppression. 4. To evaluate the tumor-promoting effects of complement on NSCLC cells.

Ficheros en este registro:
Fichero: 
Leticia Corrales Pecino.pdf
Descripción: 
Tamaño: 
7,71 MB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.